ChabioTech Obtains European Patent for Composition Treating Neurological Disorders
[Asia Economy Reporter Lee Seon-ae] Cha Biotech announced on the 10th that it has obtained a European patent for a method of proliferating neural progenitor cells and a composition for treating neurological diseases containing the proliferated neural progenitor cells.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Why This Bonus Grade?" Civil Servant Who Assaulted HR Employee... Court Rules Demotion Is Justified
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company stated, "The method of proliferating stem cells according to this invention can contribute to the mass production of stem cells, and the proliferated stem cells are expected to be usefully applied to the treatment of various diseases."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
